The potential value of near patient platelet function testing in PCI: randomised comparison of 600 mg versus 900 mg clopidogrel loading doses

Alex R. Hobson, Zeshan Qureshi, Phil Banks and Nicholas Curzen

The clinical value of dual antiplatelet therapy with aspirin and clopidogrel to reduce platelet-mediated cardiovascular events is now well established in patients with acute coronary syndromes and those receiving intracoronary stents. In the field of PCI, in particular, a large and expanding body of evidence indicates that periprocedural complication rates can be reduced by loading doses of clopidogrel given at least 6 hours before planned stenting. The superiority of 600 mg loading doses of clopidogrel over 300 mg is now widely accepted.

Dr Zeshan Qureshi

About the author

Children's doctor. London. Mental health. Global health. Medical education. TEDx talk (doctor well being).

Leave a comment